TrialPloS one2018

Pre-existing interstitial lung disease as a risk factor for pneumonitis associated with ramucirumab and paclitaxel in patients with gastric cancer: The impact of usual interstitial pneumonia.

Nobuyuki Koyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.